CRSP
CRISPR Therapeutics AG
Stock
$55.43−0.01 (−0.02%)Close Oct 2, 2026
- Capital expenditures, 2025
- $914K
- YoY, 2025
- −51.9%
- 5-year CAGR
- −45.1%
- 10-year CAGR
- −2.3%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $914K | −51.9% |
| 2024 | $1.9M | −79.9% |
| 2023 | $9.5M | −74.5% |
| 2022 | $37M | −54.5% |
| 2021 | $82M | +345.1% |
| 2020 | $18M | +174.7% |
| 2019 | $6.7M | +141.0% |
| 2018 | $2.8M | −64.5% |
| 2017 | $7.8M | +159.1% |
| 2016 | $3.0M | +161.4% |
| 2015 | $1.2M | — |